- call +1-201-465-4211
- email sales@mrinsights.biz
Animal blood is one of the main by-products of animal slaughtering and processing. It has rich protein content and high nutritional value. Plasma protein, as an important protein material, can be used for animal feed and food processing. Studies have shown that plasma proteins are enzymatically treated to obtain hydrolysates consisting of small peptides and amino acids, which are more easily digested and absorbed by the body. At the same time, they show antioxidant properties, inhibition of angiotensin converting enzyme activity, attenuation, and other functional properties and can be used as potential nutrients. Supplements, food additives, and nutraceuticals.
Scope of the Report:
This report focuses on the Animal Blood Plasma Products and Derivatives in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Plasma protein is the most important solid component in plasma, and its amino acid content is rich and its nutritional value is high. At present, it is mainly processed into plasma protein powder as livestock feed or nutritional supplement, or as a raw material or additive for various food systems [11]. Studies have shown that plasma proteins are hydrolyzed by specific enzymes to produce hydrolysates consisting of small peptides and amino acids, which are more easily digested and absorbed by the human body. At the same time, they show antioxidation, inhibition of angiotensin-converting enzyme (ACE) and attenuation. The functional properties of peptides isolated from them have been widely studied as potential nutritional supplements, food additives and nutraceuticals.
The worldwide market for Animal Blood Plasma Products and Derivatives is expected to grow at a CAGR of roughly 8.0% over the next five years, will reach 1630 million US$ in 2023, from 1030 million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Lake Immunogenics
Auckland BioSciences
Kraeber & Co. GmbH
Sigma-Aldrich
Thermo Fisher Scientific
Rocky Mountain Biologicals
LAMPIRE Biological Laboratories
Bovogen Biologicals
Proliant
ANZCO Foods
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Market Segment by Applications, can be divided into
Cell Culture Media
Food Industry
Pharmaceutical Industry
Sports Nutrition
Nutrition Supplements
Cosmetic Industry
Diagnostic Industry
Pet Food Industry
There are 15 Chapters to deeply display the global Animal Blood Plasma Products and Derivatives market.
Chapter 1, to describe Animal Blood Plasma Products and Derivatives Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Animal Blood Plasma Products and Derivatives, with sales, revenue, and price of Animal Blood Plasma Products and Derivatives, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Animal Blood Plasma Products and Derivatives, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Animal Blood Plasma Products and Derivatives market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Animal Blood Plasma Products and Derivatives sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Animal Blood Plasma Products and Derivatives Introduction
1.2 Market Analysis by Type
1.2.1 Immunoglobulin
1.2.2 Fibrinogen
1.2.3 Serum Albumin
1.2.4 Fetal Bovine Serum
1.3 Market Analysis by Applications
1.3.1 Cell Culture Media
1.3.2 Food Industry
1.3.3 Pharmaceutical Industry
1.3.4 Sports Nutrition
1.3.5 Nutrition Supplements
1.3.6 Cosmetic Industry
1.3.7 Diagnostic Industry
1.3.8 Pet Food Industry
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Lake Immunogenics
2.1.1 Business Overview
2.1.1.1 Lake Immunogenics Description
2.1.1.2 Lake Immunogenics Headquarter, Main Business and Finance Overview
2.1.2 Lake Immunogenics Animal Blood Plasma Products and Derivatives Product Introduction
2.1.2.1 Animal Blood Plasma Products and Derivatives Production Bases, Sales Regions and Major Competitors
2.1.2.2 Animal Blood Plasma Products and Derivatives Product Information
2.1.3 Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Lake Immunogenics Animal Blood Plasma Products and Derivatives Market Share in 2017
2.2 Auckland BioSciences
2.2.1 Business Overview
2.2.1.1 Auckland BioSciences Description
2.2.1.2 Auckland BioSciences Headquarter, Main Business and Finance Overview
2.2.2 Auckland BioSciences Animal Blood Plasma Products and Derivatives Product Introduction
2.2.2.1 Animal Blood Plasma Products and Derivatives Production Bases, Sales Regions and Major Competitors
2.2.2.2 Animal Blood Plasma Products and Derivatives Product Information
2.2.3 Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Auckland BioSciences Animal Blood Plasma Products and Derivatives Market Share in 2017
2.3 Kraeber & Co. GmbH
2.3.1 Business Overview
2.3.1.1 Kraeber & Co. GmbH Description
2.3.1.2 Kraeber & Co. GmbH Headquarter, Main Business and Finance Overview
2.3.2 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Product Introduction
2.3.2.1 Animal Blood Plasma Products and Derivatives Production Bases, Sales Regions and Major Competitors
2.3.2.2 Animal Blood Plasma Products and Derivatives Product Information
2.3.3 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Market Share in 2017
2.4 Sigma-Aldrich
2.4.1 Business Overview
2.4.1.1 Sigma-Aldrich Description
2.4.1.2 Sigma-Aldrich Headquarter, Main Business and Finance Overview
2.4.2 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Product Introduction
2.4.2.1 Animal Blood Plasma Products and Derivatives Production Bases, Sales Regions and Major Competitors
2.4.2.2 Animal Blood Plasma Products and Derivatives Product Information
2.4.3 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Sigma-Aldrich Animal Blood Plasma Products and Derivatives Market Share in 2017
2.5 Thermo Fisher Scientific
2.5.1 Business Overview
2.5.1.1 Thermo Fisher Scientific Description
2.5.1.2 Thermo Fisher Scientific Headquarter, Main Business and Finance Overview
2.5.2 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Product Introduction
2.5.2.1 Animal Blood Plasma Products and Derivatives Production Bases, Sales Regions and Major Competitors
2.5.2.2 Animal Blood Plasma Products and Derivatives Product Information
2.5.3 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Market Share in 2017
2.6 Rocky Mountain Biologicals
2.6.1 Business Overview
2.6.1.1 Rocky Mountain Biologicals Description
2.6.1.2 Rocky Mountain Biologicals Headquarter, Main Business and Finance Overview
2.6.2 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Product Introduction
2.6.2.1 Animal Blood Plasma Products and Derivatives Production Bases, Sales Regions and Major Competitors
2.6.2.2 Animal Blood Plasma Products and Derivatives Product Information
2.6.3 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Market Share in 2017
2.7 LAMPIRE Biological Laboratories
2.7.1 Business Overview
2.7.1.1 LAMPIRE Biological Laboratories Description
2.7.1.2 LAMPIRE Biological Laboratories Headquarter, Main Business and Finance Overview
2.7.2 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Product Introduction
2.7.2.1 Animal Blood Plasma Products and Derivatives Production Bases, Sales Regions and Major Competitors
2.7.2.2 Animal Blood Plasma Products and Derivatives Product Information
2.7.3 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Market Share in 2017
2.8 Bovogen Biologicals
2.8.1 Business Overview
2.8.1.1 Bovogen Biologicals Description
2.8.1.2 Bovogen Biologicals Headquarter, Main Business and Finance Overview
2.8.2 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Product Introduction
2.8.2.1 Animal Blood Plasma Products and Derivatives Production Bases, Sales Regions and Major Competitors
2.8.2.2 Animal Blood Plasma Products and Derivatives Product Information
2.8.3 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Bovogen Biologicals Animal Blood Plasma Products and Derivatives Market Share in 2017
2.9 Proliant
2.9.1 Business Overview
2.9.1.1 Proliant Description
2.9.1.2 Proliant Headquarter, Main Business and Finance Overview
2.9.2 Proliant Animal Blood Plasma Products and Derivatives Product Introduction
2.9.2.1 Animal Blood Plasma Products and Derivatives Production Bases, Sales Regions and Major Competitors
2.9.2.2 Animal Blood Plasma Products and Derivatives Product Information
2.9.3 Proliant Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Proliant Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Proliant Animal Blood Plasma Products and Derivatives Market Share in 2017
2.10 ANZCO Foods
2.10.1 Business Overview
2.10.1.1 ANZCO Foods Description
2.10.1.2 ANZCO Foods Headquarter, Main Business and Finance Overview
2.10.2 ANZCO Foods Animal Blood Plasma Products and Derivatives Product Introduction
2.10.2.1 Animal Blood Plasma Products and Derivatives Production Bases, Sales Regions and Major Competitors
2.10.2.2 Animal Blood Plasma Products and Derivatives Product Information
2.10.3 ANZCO Foods Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 ANZCO Foods Animal Blood Plasma Products and Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global ANZCO Foods Animal Blood Plasma Products and Derivatives Market Share in 2017
3 Global Animal Blood Plasma Products and Derivatives Market Competition, by Manufacturer
3.1 Global Animal Blood Plasma Products and Derivatives Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Animal Blood Plasma Products and Derivatives Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Animal Blood Plasma Products and Derivatives Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Animal Blood Plasma Products and Derivatives Manufacturer Market Share in 2017
3.4.2 Top 5 Animal Blood Plasma Products and Derivatives Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Animal Blood Plasma Products and Derivatives Market Analysis by Regions
4.1 Global Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Regions
4.1.1 Global Animal Blood Plasma Products and Derivatives Sales by Regions (2013-2018)
4.1.2 Global Animal Blood Plasma Products and Derivatives Revenue by Regions (2013-2018)
4.2 North America Animal Blood Plasma Products and Derivatives Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Animal Blood Plasma Products and Derivatives Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Animal Blood Plasma Products and Derivatives Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales, Revenue and Growth Rate (2013-2018)
5 North America Animal Blood Plasma Products and Derivatives by Countries, Type, Application and Manufacturers
5.1 North America Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Countries
5.1.1 North America Animal Blood Plasma Products and Derivatives Sales by Countries (2013-2018)
5.1.2 North America Animal Blood Plasma Products and Derivatives Revenue by Countries (2013-2018)
5.1.3 United States Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
5.1.4 Canada Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
5.1.5 Mexico Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
5.2 North America Animal Blood Plasma Products and Derivatives Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Animal Blood Plasma Products and Derivatives Sales by Manufacturers (2016-2017)
5.2.2 North America Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (2016-2017)
5.3 North America Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Animal Blood Plasma Products and Derivatives Sales and Sales Share by Type (2013-2018)
5.3.2 North America Animal Blood Plasma Products and Derivatives Revenue and Revenue Share by Type (2013-2018)
5.4 North America Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Animal Blood Plasma Products and Derivatives Sales and Sales Share by Application (2013-2018)
5.4.2 North America Animal Blood Plasma Products and Derivatives Revenue and Revenue Share by Application (2013-2018)
6 Europe Animal Blood Plasma Products and Derivatives by Countries, Type, Application and Manufacturers
6.1 Europe Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Countries
6.1.1 Europe Animal Blood Plasma Products and Derivatives Sales by Countries (2013-2018)
6.1.2 Europe Animal Blood Plasma Products and Derivatives Revenue by Countries (2013-2018)
6.1.3 Germany Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
6.1.4 UK Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
6.1.5 France Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
6.1.6 Russia Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
6.1.7 Italy Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
6.2 Europe Animal Blood Plasma Products and Derivatives Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Animal Blood Plasma Products and Derivatives Sales by Manufacturers (2016-2017)
6.2.2 Europe Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (2016-2017)
6.3 Europe Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Animal Blood Plasma Products and Derivatives Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Animal Blood Plasma Products and Derivatives Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Animal Blood Plasma Products and Derivatives Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Animal Blood Plasma Products and Derivatives Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Animal Blood Plasma Products and Derivatives by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Revenue by Countries (2013-2018)
7.1.3 China Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
7.1.4 Japan Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
7.1.5 Korea Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
7.1.6 India Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Revenue and Revenue Share by Application (2013-2018)
8 South America Animal Blood Plasma Products and Derivatives by Countries, Type, Application and Manufacturers
8.1 South America Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Countries
8.1.1 South America Animal Blood Plasma Products and Derivatives Sales by Countries (2013-2018)
8.1.2 South America Animal Blood Plasma Products and Derivatives Revenue by Countries (2013-2018)
8.1.3 Brazil Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
8.1.4 Argentina Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
8.1.5 Colombia Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
8.2 South America Animal Blood Plasma Products and Derivatives Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Animal Blood Plasma Products and Derivatives Sales by Manufacturers (2016-2017)
8.2.2 South America Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (2016-2017)
8.3 South America Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Animal Blood Plasma Products and Derivatives Sales and Sales Share by Type (2013-2018)
8.3.2 South America Animal Blood Plasma Products and Derivatives Revenue and Revenue Share by Type (2013-2018)
8.4 South America Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Animal Blood Plasma Products and Derivatives Sales and Sales Share by Application (2013-2018)
8.4.2 South America Animal Blood Plasma Products and Derivatives Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Animal Blood Plasma Products and Derivatives by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
9.1.4 UAE Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
9.1.5 Egypt Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
9.1.7 South Africa Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue and Revenue Share by Application (2013-2018)
10 Global Animal Blood Plasma Products and Derivatives Market Segment by Type
10.1 Global Animal Blood Plasma Products and Derivatives Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Animal Blood Plasma Products and Derivatives Sales and Market Share by Type (2013-2018)
10.1.2 Global Animal Blood Plasma Products and Derivatives Revenue and Market Share by Type (2013-2018)
10.2 Immunoglobulin Sales Growth and Price
10.2.1 Global Immunoglobulin Sales Growth (2013-2018)
10.2.2 Global Immunoglobulin Price (2013-2018)
10.3 Fibrinogen Sales Growth and Price
10.3.1 Global Fibrinogen Sales Growth (2013-2018)
10.3.2 Global Fibrinogen Price (2013-2018)
10.4 Serum Albumin Sales Growth and Price
10.4.1 Global Serum Albumin Sales Growth (2013-2018)
10.4.2 Global Serum Albumin Price (2013-2018)
10.5 Fetal Bovine Serum Sales Growth and Price
10.5.1 Global Fetal Bovine Serum Sales Growth (2013-2018)
10.5.2 Global Fetal Bovine Serum Price (2013-2018)
11 Global Animal Blood Plasma Products and Derivatives Market Segment by Application
11.1 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2013-2018)
11.2 Cell Culture Media Sales Growth (2013-2018)
11.3 Food Industry Sales Growth (2013-2018)
11.4 Pharmaceutical Industry Sales Growth (2013-2018)
11.5 Sports Nutrition Sales Growth (2013-2018)
11.6 Nutrition Supplements Sales Growth (2013-2018)
11.7 Cosmetic Industry Sales Growth (2013-2018)
11.8 Diagnostic Industry Sales Growth (2013-2018)
11.9 Pet Food Industry Sales Growth (2013-2018)
12 Animal Blood Plasma Products and Derivatives Market Forecast (2018-2023)
12.1 Global Animal Blood Plasma Products and Derivatives Sales, Revenue and Growth Rate (2018-2023)
12.2 Animal Blood Plasma Products and Derivatives Market Forecast by Regions (2018-2023)
12.2.1 North America Animal Blood Plasma Products and Derivatives Market Forecast (2018-2023)
12.2.2 Europe Animal Blood Plasma Products and Derivatives Market Forecast (2018-2023)
12.2.3 Asia-Pacific Animal Blood Plasma Products and Derivatives Market Forecast (2018-2023)
12.2.4 South America Animal Blood Plasma Products and Derivatives Market Forecast (2018-2023)
12.2.5 Middle East and Africa Animal Blood Plasma Products and Derivatives Market Forecast (2018-2023)
12.3 Animal Blood Plasma Products and Derivatives Market Forecast by Type (2018-2023)
12.3.1 Global Animal Blood Plasma Products and Derivatives Sales Forecast by Type (2018-2023)
12.3.2 Global Animal Blood Plasma Products and Derivatives Market Share Forecast by Type (2018-2023)
12.4 Animal Blood Plasma Products and Derivatives Market Forecast by Application (2018-2023)
12.4.1 Global Animal Blood Plasma Products and Derivatives Sales Forecast by Application (2018-2023)
12.4.2 Global Animal Blood Plasma Products and Derivatives Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Animal Blood Plasma Products and Derivatives Picture
Table Product Specifications of Animal Blood Plasma Products and Derivatives
Figure Global Animal Blood Plasma P
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
